Drug Markets/Erenumab-Aooe

Erenumab-Aooe

2 NDCs across 1 manufacturer|0 Generic,2 Brand

▸ More about this market

In 2024, Medicare Part D spent $306 million on Erenumab-Aooe across 338,000 claims for 56,000 beneficiaries.

Erenumab-Aooe is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $753.38 to $753.58 per MLa 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$753.38 – $753.58

per ML

7d Activity

110 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing ERENUMAB-AOOE

Drug Portfolio

2 NDCs total, 2 shown

Drug Price 7d Change
AIMOVIG 70 MG/ML AUTOINJECTOR
$753.5827
per ML
+0.06%
AIMOVIG 140 MG/ML AUTOINJECTOR
$753.3819
per ML
-0.01%

Frequently Asked Questions

How much does Medicare spend on Erenumab-Aooe?

In 2024, Medicare Part D spent $306 million on Erenumab-Aooe across 338,000 claims for 56,000 beneficiaries.

How many Erenumab-Aooe products are on the market?

The Erenumab-Aooe drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Erenumab-Aooe?

NADAC reference prices for Erenumab-Aooe range from $753.3819 to $753.5827 per ML — a 0% difference between cheapest and most expensive.

Which manufacturers make Erenumab-Aooe?

1 manufacturer lists Erenumab-Aooe in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (2).

How has the price of Erenumab-Aooe changed recently?

Over the past 7 days, 1 Erenumab-Aooe NDC rose and 1 fell, with a market-wide average change of +0.0%.